Therefore, the MMTV-myr-Akt1 transgenic mice could be useful for exploring the underlying mechanisms of ER-positive breast cancer acquiring resistance to tamoxifen and developing metastatic disease. This evidence concerns the gene AKT1 and metastatic neoplasm.